{"id":5115,"date":"2025-11-04T21:28:58","date_gmt":"2025-11-04T18:28:58","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=5115"},"modified":"2025-11-05T00:18:00","modified_gmt":"2025-11-04T21:18:00","slug":"sarepta-dmd-exon-skipping-therapies-fail-confirmatory-study-stock-price-down","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/zh\/sarepta-dmd-exon-skipping-therapies-fail-confirmatory-study-stock-price-down\/","title":{"rendered":"Sarepta\u516c\u53f8DMD\u5916\u663e\u5b50\u8df3\u8dc3\u7597\u6cd5\u9a8c\u8bc1\u6027\u7814\u7a76\u5931\u8d25\uff0c\u80a1\u4ef7\u4e0b\u8dcc"},"content":{"rendered":"<p class=\"wp-block-paragraph\">Sarepta Therapeutics&#039;\u7a81\u53d8\u5e26\u6765\u7684\u56f0\u96be\u53ea\u4f1a\u8d8a\u6765\u8d8a\u4e25\u91cd\u3002\u8be5\u516c\u53f8\u53d1\u73b0\uff0c\u5728\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u60a3\u8005\u4e2d\uff0c\u4ed6\u4eec\u7684\u5916\u663e\u5b50\u8df3\u8dc3\u7597\u6cd5Vyondys 53\u548cAmondys 45\u5e76\u6ca1\u6709\u663e\u8457\u6539\u5584\u8fd0\u52a8\u529f\u80fd\u3002 <a href=\"https:\/\/investorrelations.sarepta.com\/news-releases\/news-release-details\/sarepta-therapeutics-announces-third-quarter-2025-financial\" target=\"_blank\" rel=\"noreferrer noopener\">Sarepta\u516c\u544a<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u5468\u4e8c\u76d8\u524d\u4ea4\u6613\u4e2d\uff0c\u8be5\u751f\u7269\u79d1\u6280\u516c\u53f8\u80a1\u4ef7\u4e3a $15.60\uff0c\u8f83\u5468\u4e00\u6536\u76d8\u4ef7 $24.45 \u4e0b\u8dcc\u4e86 36%\u3002.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u5a01\u5ec9\u00b7\u5e03\u83b1\u5c14\u5206\u6790\u5e08\u5468\u4e8c\u4e0a\u5348\u5728\u4e00\u5c01\u81f4\u5ba2\u6237\u7684\u4fe1\u4e2d\u5199\u9053\uff0c\u5c3d\u7ba1Sarepta\u516c\u53f8\u6301\u4e50\u89c2\u6001\u5ea6\uff0c\u4f46\u8fd9\u4e9b\u836f\u7269\u7684\u8bd5\u9a8c\u7ed3\u679c\u4ee4\u5176\u524d\u666f\u8499\u4e0a\u9634\u5f71\u3002\u4ed6\u4eec\u8865\u5145\u9053\uff1a\u2019\u6211\u4eec\u8ba4\u4e3aESSENCE\u8bd5\u9a8c\u672a\u80fd\u8fbe\u5230\u5176\u4e3b\u8981\u76ee\u6807\u662f\u4e00\u4e2a\u8d1f\u9762\u8fdb\u5c55\u3002\u201c<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u5c3d\u7ba1\u7ba1\u7406\u5c42\u786e\u4fe1 Vyondys 53 \u548c Amondys 45 \u4e0d\u4f1a\u56e0\u6b64\u5931\u53bb\u4e0a\u5e02\u8bb8\u53ef\uff0c\u4f46\u6211\u4eec\u4ecd\u7136\u8868\u793a\u6000\u7591\uff0c\u5e76\u8ba4\u4e3a\u8be5\u80a1\u7684\u53cd\u5e94\uff08\u76d8\u540e\u4e0b\u8dcc 371 \u81f3 143\uff09\u8868\u660e\u6295\u8d44\u8005\u540c\u6837\u62c5\u5fc3\u8fd9\u4e24\u79cd\u836f\u7269\u7684\u672a\u6765\u3002.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u5173\u6ce8\u6b64\u9875\u9762<\/strong>&nbsp;&gt;&gt;&gt;&nbsp;<a href=\"https:\/\/dmdwarrior.com\/zh\/dmd-therapies\/\" target=\"_blank\" rel=\"noreferrer noopener\">\u6240\u6709\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u7684\u4e34\u5e8a\u8bd5\u9a8c<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Sarepta Therapeutics&#8217; difficulties only get worse. In patients with Duchenne muscular dystrophy, the business found that their exon-skipping treatments, Vyondys 53 and Amondys 45, did not considerably enhance motor function. >>> Sarepta Announcement Tuesday&#8217;s pre-market trading saw the biotech selling at $15.60, a 36% decrease from Monday&#8217;s closing share price of $24.45. William Blair analysts [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5117,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[453,77,178,65,394],"class_list":["post-5115","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-amondys-45","tag-exon-skipping","tag-exon-skipping-therapies","tag-sarepta","tag-vyondys-53"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/posts\/5115","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/comments?post=5115"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/posts\/5115\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/media\/5117"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/media?parent=5115"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/categories?post=5115"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/tags?post=5115"}],"curies":[{"name":"\u53ef\u6e7f\u6027\u7c89\u5242","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}